COLD-FX(R) Receives Certification from NSF International

Afexa Life Sciences Inc. ("Afexa") today announced COLD-FX(R) has received the highest sports certification in North America from the leading product safety and banned substances testing body for elite athletes. The certification comes from NSF International - a U.S. based not-for-profit public health and safety organization - under its NSF Certified for Sport(TM) program. NSF, which is recognized by the Vancouver Organizing Committee for the 2010 Olympic and Paralympic Winter Games (VANOC), the Canadian Centre for Ethics in Sport, the National Football League, Major League Baseball and the PGA has granted COLD-FX special certification under its Certified for Sport program following a rigorous testing program.

Ed Wyszumiala, General Manager of NSF's Dietary Supplements Certification programs says, "COLD-FX received this sports certification after undergoing a rigorous testing program which included a series of Good Manufacturing Practices (GMP) facility audits, label claim testing/verification and banned substance testing for over 130 analytes. All of these requirements were met, in addition to meeting the requirements in NSF/ANSI(i) Standard 173, which is the only accredited American National Standard for dietary supplements and ingredients."

With ongoing monitoring and testing, athletes can feel confident that COLD-FX has met and will continue to meet all of NSF's certification requirements to ensure the product is free of banned substances.

Earlier this year COLD-FX was chosen as the Official Cold and Flu Remedy of the Vancouver 2010 Olympic and Paralympic Winter Games. COLD-FX's high standards for safety and efficacy were key factors in it being selected for this important recognition.

"We congratulate COLD-FX on achieving this important certification and we are pleased we can showcase this product to the world as an example of Canadian scientific ingenuity and innovation," says VANOC chief medical officer Dr. Jack Taunton. "Afexa has done praiseworthy and unique research in the field of cold and flu medicine and will help keep our workforce healthy during the Games as we prepare to host the world in 2010."

The Canadian Centre for Ethics in Sport (CCES) - the body which administers Canada's doping control program - praised COLD-FX's certification. Paul Melia, CEO of CCES says, "The certification demonstrates Afexa's leadership and corporate responsibility to Canadian athletes. I hope this will set an example for other supplement and sport nutrition companies in Canada."

Afexa's Chief Scientific Officer Dr. Jacqueline Shan says, "COLD-FX has a long history of use by amateur and professional athletes in Canada due to its effectiveness and safety backed by a decade of science and clinical trials. Our ChemBioPrint(R) standardization technology ensures batch to batch consistency. We are pleased that NSF certification supports the results of a ground-breaking clinical trial conducted by a team of sports researchers at the University of Manitoba. It concluded that COLD-FX does not contain any IOC banned or restricted substances and does not produce or induce banned substances in the body. The results were published in a leading peer-reviewed sports/medicine journal in 2004. Afexa is committed to developing products that are both safe and effective for elite athletes as well as the general public."

COLD-FX is widely used by Canadian Olympians and was first recommended to elite athletes by the Canadian Sport Centre Calgary in 2003. Earlier this year all of the Canadian Sport Centres decided to recommend it to their athletes to help keep them in top health in this particularly challenging flu season. Canadian Sport Centre Calgary President Dale Henwood says, "This certification is an important achievement. It provides additional confirmation for athletes who regard COLD-FX as a key part of their health regimen." Afexa is providing COLD-FX to 1,500 athletes, coaches, trainers and support staff at sports centres in seven provinces where the country's elite athletes train, including those preparing for the 2010 Winter Games.

Olympic Gold Medalist Clara Hughes says, "Many of my teammates and I rely upon it. I've gone through dozens and dozens of tests since I started taking COLD-FX over six years ago and each time they come back negative for banned substances. NSF certification is just further confirmation that athletes can take it without having to worry."

COLD-FX will be the exclusive cold and flu remedy available at general stores within the Olympic and Paralympic Villages in Vancouver and Whistler. VANOC has arranged with Afexa to make COLD-FX available to close to 40,000 volunteers, staff and media during the 2010 Winter Games.

(i)American National Standards Institute

ABOUT NSF International

NSF International, an independent, not-for-profit organization, helps protect consumers by certifying products and writing standards for food, water and consumer goods ( Founded in 1944, NSF is committed to protecting public health and safety worldwide and serves manufacturers in over 100 countries. NSF's a World Health Organization Collaborating Centre for Food and Water Safety and Indoor Environment. NSF's Dietary Supplement Certification program verifies, what is on the label is in the bottle and that the product does not contain undeclared ingredients or contaminants. NSF's Athletic Banned Substances Certification program builds on this dietary supplement certification program by including screening that ensures the product does not contain banned or prohibited substances. Major League Baseball (MLB), the MLB Player's Association, NFL, the NFL Player's Association, PGA, LPGA and the Canadian Centre for Ethics in Sports have all chosen NSF to help verify the products their athletes use are safe and free of banned substances.


COLD-FX(R) is the # 1 physician recommended natural cold remedy in Canada and for the past four years has also been chosen as the # 1 pharmacist recommended natural cold remedy. It has been approved by Health Canada to help reduce the frequency, severity, duration of cold and flu symptoms by boosting the immune system. It has undergone over 10 clinical trials at both American and Canadian universities including a four city, three university trial which showed that COLD-FX significantly improves the flu shot's effectiveness and provides greater protection against colds and flu. COLD-FX has been chosen as the Official Cold and Flu Remedy of the 2010 Olympic and Paralympic Winter Games. COLD-FX and the Afexa logo are trademarks owned by Afexa Life Sciences Inc.

Forwarding looking Statement

This news release contains certain forward-looking statements and information within the meaning of applicable securities laws, which reflect current expectations of the management of Afexa Life Sciences Inc. (the "Company") regarding future events or the Company's future performance, including, without limitation, statements relating to the timing and/or initiation of clinical trials, clinical trial results, the introduction of new products, associated regulatory clearances, economic or financial trends or expectations, financing, acceptance of the Company's products in the marketplace and the hiring or retention of personnel. Forward-looking statements are often, but not always, identified by the use of words such as "expect", "anticipate", "seek", "aim", "continue", "estimate", "objective", "ongoing", "may", "will", "would", "project", "predict", "potential", "could", "should", "might", "believe", "plan", "target", "intend" and similar expressions. All statements other than statements of historical fact contained in this news release may be forward-looking statements. The forward-looking information included in this document does not guarantee future performance and should not be unduly relied upon. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information, including, without limitation, the impact of competition, the incidence of cold and flu, consumer confidence and spending levels, general economic conditions, interest and currency exchange rates, unseasonable weather patterns, the cost and availability of capital and grants/funding, product development uncertainties, labour market challenges and consumer acceptance of COLD-FX in other markets. The Company believes that the expectations and assumptions reflected in the forward-looking information contained herein are reasonable but no assurance can be given that these expectations and assumptions are correct or that that the results, performance or achievements expressed in, or implied by, forward-looking statements herein will occur, or if they do, that any benefits may be derived from them. The Company can give no assurance that new product development initiatives will lead to new product commercialization. The Company can give no assurance that its sponsorship in the 2010 Winter Olympics or its NSF certification will have any impact on sales of COLD-FX. The Company assumes no duty to update or revise forward looking information, except as may be required pursuant to applicable laws. All forward-looking information is expressly qualified in its entirety by this cautionary statement. Further information regarding risks and uncertainties relating to the Company and its securities can be found in the disclosure documents filed by the Company with the securities regulatory authorities, available at The Company claims exemption under U.S. SEC Rule 12g3-2(b).

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.